AbbVie wins FDA approval for Juvmo, a once-daily pill for Parkinson's disease

AbbVie has received FDA approval for Juvmo, a once-daily oral pill to treat Parkinson's disease, according to a news report. The approval clears the drug for the US market.

Detected & updated continuously · Source: Nebula